Guidelines for Delivery in Preeclampsia
Delivery timing in preeclampsia should be based primarily on gestational age and the presence of maternal or fetal complications, with immediate delivery indicated at ≥37 weeks' gestation and for any severe features regardless of gestational age. 1
Gestational Age-Based Delivery Guidelines
- ≥37 weeks' gestation: Immediate delivery is recommended for all women with preeclampsia 1
- 34-37 weeks' gestation: Expectant management with close monitoring is appropriate in the absence of severe features 1
- <34 weeks' gestation: Conservative (expectant) management at a center with Maternal and Fetal Medicine expertise is recommended when maternal and fetal conditions are stable 1
- <24 weeks' gestation (limits of viability): Counseling about possible pregnancy termination should be provided due to high maternal risks and poor fetal outcomes 1
Indications for Immediate Delivery Regardless of Gestational Age
Delivery is necessary when any of the following conditions develop 1:
- Uncontrolled severe hypertension despite using ≥3 classes of antihypertensives in appropriate doses 1
- Maternal pulse oximetry <90% 1
- Progressive deterioration in liver function, creatinine, hemolysis, or platelet count 1
- Ongoing neurological features (severe intractable headache, repeated visual scotomata, eclampsia) 1
- Pulmonary edema 1
- Placental abruption 1
- Non-reassuring fetal status or reversed end-diastolic flow in umbilical artery Doppler 1
Management During Expectant Approach
Maternal Monitoring
- Blood pressure monitoring 1
- Repeated assessments for proteinuria if not already present 1
- Clinical assessment including clonus 1
- Twice weekly blood tests for hemoglobin, platelet count, liver enzymes, creatinine, and uric acid 1
- MgSO₄ for seizure prophylaxis in women with severe hypertension or neurological symptoms 1, 2
Fetal Monitoring
- Initial assessment of fetal biometry, amniotic fluid, and umbilical artery Doppler 1
- Follow-up ultrasound every 2 weeks if initial assessment was normal 1
- More frequent monitoring in the presence of fetal growth restriction 1
Special Considerations
Preeclampsia with Severe Features at 34-37 Weeks
- The American Association for the Study of Liver Diseases recommends delivery at 34 weeks for preeclampsia with severe features 1
- This differs slightly from ISSHP guidelines which allow for individualized assessment between 34-37 weeks 1
HELLP Syndrome
- Expeditious delivery after maternal stabilization is recommended when HELLP syndrome develops 1
- Abdominal imaging should be performed to rule out hepatic complications 1
Magnesium Sulfate Administration
- For severe preeclampsia or eclampsia, the total initial dose is 10-14g of magnesium sulfate 2
- Intravenously, 4-5g in 250mL of appropriate solution may be infused 2
- Therapy should continue until paroxysms cease, with a serum magnesium level of 6 mg/100mL considered optimal for seizure control 2
- Total daily dose should not exceed 30-40g 2
Important Caveats
- Do not attempt to classify preeclampsia as mild versus severe clinically, as all cases may rapidly progress to emergencies 1
- Neither serum uric acid nor the level of proteinuria should be used as an indication for delivery 1
- The level of blood pressure alone is not a reliable way to stratify immediate risk, as serious organ dysfunction can develop at relatively mild levels of hypertension 1
- Plasma volume expansion is not recommended routinely in women with preeclampsia 1
- Between 24-34 weeks, antenatal corticosteroids should be administered to promote fetal lung maturity before delivery 3